Following an extremely successful event in Boston last December, Gene Therapy for Neurological Disorders Europe will be hitting Amsterdam this July and uniting industry leaders to help them overcome their translational challenges and successfully bring their CNS gene therapy candidate into the clinic.
List view / Grid view
The inaugural Innate Immune Stimulating Therapies Summit has arrived with a dedicated focus on achieving safe and effective clinical and commercial translation of STING and TLR therapies.
The Bioprocessing Summit Europe brings together leading bioprocessing, analytical and formulation scientists to discuss the latest developments and trends in cell culture, cell line, protein expression, recovery, purification, cell and gene therapy manufacturing, and new for 2020, analytical characterization, formulation and aggregation.
Immunogenicity compromises both the efficacy and safety of gene therapies and thus represents one of the most prominent challenges that must be overcome in the field.
Advanced Therapies is Europe’s most important advanced therapies conference and exhibition.
Discovery on Target (DOT) is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals.
The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.